91 related articles for article (PubMed ID: 25731500)
1. [Examination of outcomes after conversion surgery for Stage IVGastric cancer in our hospital].
Hagino S; Kurata T; Makita N; Tsuneda A; Iwata K; Kiriyama M
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2293-5. PubMed ID: 25731500
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of conversion gastrectomy for treatment of Stage IV advanced gastric cancer].
Funaki H; Fujita J; Morioka E; Kaida D; Ohnishi T; Ohno Y; Tomita Y; Noguchi M; Fujita H; Kinami S; Nakano Y; Ueda N; Kosaka T
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1615-7. PubMed ID: 24393866
[TBL] [Abstract][Full Text] [Related]
3. Significance of surgical treatment in multimodal therapy for stage IV highly advanced gastric cancer.
Yabusaki H; Nashimoto A; Matsuki A; Aizawa M
Hepatogastroenterology; 2013; 60(122):377-81. PubMed ID: 22975650
[TBL] [Abstract][Full Text] [Related]
4. Induction chemotherapy with S-1 plus cisplatin followed by surgery for treatment of gastric cancer with peritoneal dissemination.
Okabe H; Ueda S; Obama K; Hosogi H; Sakai Y
Ann Surg Oncol; 2009 Dec; 16(12):3227-36. PubMed ID: 19777180
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of TS-1 combined with cisplatin for neoadjuvant chemotherapy in patients with advanced gastric cancer].
Yabusaki H; Nashimoto A; Tanaka O
Gan To Kagaku Ryoho; 2003 Nov; 30(12):1933-40. PubMed ID: 14650962
[TBL] [Abstract][Full Text] [Related]
6. [A case of recurrent gastric cancer successfully treated with TS-1+CDDP chemotherapy].
Ogasawara T; Ootsuka Y; Nakano S; Shida T; Nomura S; Kin M; Takahashi M; Komatsu T
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2428-9. PubMed ID: 25731546
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of surgery aiming at curative resection in good responder to induction chemotherapy for gastric cancer with distant metastases.
Han DS; Suh YS; Kong SH; Lee HJ; Im SA; Bang YJ; Kim WH; Yang HK
J Surg Oncol; 2013 Apr; 107(5):511-6. PubMed ID: 23090791
[TBL] [Abstract][Full Text] [Related]
8. [Complete response of primary tumor in a case of advanced gastric cancer with liver metastasis treated by TS-1 plus divided administration of CDDP].
Oka H; Hayashi T; Sakagami T; Shimoyama T; Hyon B; Kin Y; Hama M; Yamamura M; Shimazu T; Kyo N; Kawasaki Y; Ohturu M; Senba S
Gan To Kagaku Ryoho; 2003 Oct; 30(10):1493-8. PubMed ID: 14584284
[TBL] [Abstract][Full Text] [Related]
9. [A case of advanced gastric cancer successfully treated with TS-1/CDDP combination chemotherapy, able to maintain CR for more than two years against multiple liver metastases].
Meguro E; Kimura T; Noda Y; Matsumoto Y; Irinoda T; Hayakawa Y; Kobayashi M; Takagane A; Hioki J
Gan To Kagaku Ryoho; 2007 Feb; 34(2):249-52. PubMed ID: 17301537
[TBL] [Abstract][Full Text] [Related]
10. [Cisplatin and S-1 combination therapy after reduction surgery for stage IV gastric cancer].
Taniwaki S; Saruwatari A; Yoshida T; Mizoguchi A; Kitasato Y; Kitamura T; Hidaka A; Shiota K; Kuroda H; Tanaka M; Higashi T; Iwanaga Y; Ogata Y
Gan To Kagaku Ryoho; 2009 Feb; 36(2):279-82. PubMed ID: 19223745
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer.
Barone C; Cassano A; Pozzo C; D'Ugo D; Schinzari G; Persiani R; Basso M; Brunetti IM; Longo R; Picciocchi A
Oncology; 2004; 67(1):48-53. PubMed ID: 15459495
[TBL] [Abstract][Full Text] [Related]
12. Clinical profile of carcinoma stomach at a tertiary care hospital in south India.
Sambasivaiah K; Ibrarullah M; Reddy MK; Reddy PV; Wagholikar G; Jaiman S; Reddy DG; Sarma KV; Hegde GN
Trop Gastroenterol; 2004; 25(1):21-6. PubMed ID: 15303466
[TBL] [Abstract][Full Text] [Related]
13. [Therapeutic outcome and prognosis in S-1+CDDP chemotherapy for advanced gastric cancer--postoperative histopathological assessment].
Tanemura H; Oshita H; Yamada M; Hatoh T; Adachi T; Matsui K; Tomita E; Sugiyama A; Yamada T
Gan To Kagaku Ryoho; 2010 Mar; 37(3):447-51. PubMed ID: 20332681
[TBL] [Abstract][Full Text] [Related]
14. [Neoadjuvant chemotherapy using TS-1 and CDDP against large type 3/Type 4/Bulky N 2 advanced gastric cancer].
Tanemura H; Oshita H; Kanno A; Kusakabe M; Hatoh T; Yamada M; Adachi T; Nishio K; Saito S; Tomita E; Sugiyama A; Yamada T
Gan To Kagaku Ryoho; 2005 Dec; 32(13):2079-85. PubMed ID: 16352932
[TBL] [Abstract][Full Text] [Related]
15. A phase II study of docetaxel and oxaliplatin combination in recurrent gastric cancer patients after fluoropyrimidine and/or cisplatin adjuvant treatment: a Korean Cancer Study Group Protocol ST06-02.
Choi YH; Oh SC; Kim JS; Nam SH; Kim BS; Cho SH; Chung IJ; Song EK; Yim CY; Baek JH; Jeung HC; Hong YS; Yang SH; Kang HJ
Cancer Chemother Pharmacol; 2012 Nov; 70(5):665-72. PubMed ID: 22926638
[TBL] [Abstract][Full Text] [Related]
16. FLEP chemotherapy for alpha-fetoprotein-producing gastric cancer.
Kochi M; Fujii M; Kaiga T; Takahashi T; Morishita Y; Kobayashi M; Kasakura Y; Takayama T
Oncology; 2004; 66(6):445-9. PubMed ID: 15452373
[TBL] [Abstract][Full Text] [Related]
17. A pilot study of preoperative and postoperative chemotherapy in patients with operable gastric cancer: Australasian Gastrointestinal Trials Group Study 9601.
Findlay M; Storey D; Gebski V; Hargreaves C; Cullingford G; Boyer M; Trotter J; Archer S; Davidson A; Johnston P; Yuen J; Dhillon H; Della-Fiorentina S; Richardson G; Truskett P; Goldstein D;
ANZ J Surg; 2007 Apr; 77(4):247-52. PubMed ID: 17388828
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemotherapy followed by salvage surgery: effect on survival of patients with primary noncurative gastric cancer.
Yano M; Shiozaki H; Inoue M; Tamura S; Doki Y; Yasuda T; Fujiwara Y; Tsujinaka T; Monden M
World J Surg; 2002 Sep; 26(9):1155-9. PubMed ID: 12209246
[TBL] [Abstract][Full Text] [Related]
19. [Combination therapy of S-1 and 24-h infusion of cisplatin after palliative gastrectomy for stage IV gastric cancer].
Ina K; Hibi S; Furuta R; Takeuchi Y; Nagao S; Kayukawa S; Masaki A; Kataoka T
Gan To Kagaku Ryoho; 2010 Feb; 37(2):251-4. PubMed ID: 20154479
[TBL] [Abstract][Full Text] [Related]
20. [The Implications of Conversion Surgery for Stage Ⅳ Gastric Cancer].
Uraoka M; Higashida M; Ueno M; Mineta S; Okamoto Y; Kubota H; Watanabe Y; Okada T; Tsuruta A; Fujiwara Y; Ueno T
Gan To Kagaku Ryoho; 2018 Dec; 45(13):1797-1799. PubMed ID: 30692357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
